Dosimetric Predictors of Sexual Function Decline Following Low-Dose-Rate Brachytherapy for Prostate Cancer (PCa)

被引:1
|
作者
Mian, O. Y. [1 ]
Robertson, S. P. [2 ]
Narang, A. [1 ]
Agarwal, S. [3 ]
Bae, H. J. [2 ]
McNutt, T. R. [2 ]
Tran, P. T. [1 ]
DeWeese, T. L. [2 ]
Song, D. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] George Washington Sch Med, Washington, DC USA
关键词
D O I
10.1016/j.ijrobp.2015.07.293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
280
引用
收藏
页码:S123 / S123
页数:1
相关论文
共 50 条
  • [31] A novel perineal shield for low-dose-rate prostate brachytherapy
    Weiner, Joseph P.
    Schwartz, David
    Safdieh, Joseph
    Polubarov, Alex
    Telly, Tejas
    Worth, Matthew
    Schreiber, David
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (03) : 197 - 202
  • [32] Relapse patterns after low-dose-rate prostate brachytherapy
    Lamb, David S.
    Greig, Lynne
    FitzJohn, Trevor
    Russell, Grant L.
    Nacey, John N.
    Iupati, Douglas
    Woods, Lisa
    [J]. BRACHYTHERAPY, 2021, 20 (02) : 291 - 295
  • [33] PREDICTORS OF URINARY TOXICITY WITH MRI-ASSISTED RADIOSURGERY FOR LOW-DOSE-RATE PROSTATE BRACHYTHERAPY
    Boyce-Fappiano, David
    Bathala, Tharakeswara
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S45 - S46
  • [34] Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancer
    Langley, Stephen
    Uribe, Jennifer
    Uribe-Lewis, Santiago
    Franklin, Adrian
    Perna, Carla
    Horton, Alex
    Cunningham, Melanie
    Higgins, Donna
    Deering, Claire
    Khaksar, Sara
    Laing, Robert
    [J]. BJU INTERNATIONAL, 2020, 125 (03) : 383 - 390
  • [35] Low toxicity of focal low-dose-rate (LDR) brachytherapy for intermediate risk prostate cancer
    Harkin, Timothy
    Smyth, Lloyd
    Anderson, Elliot
    O'Sullivan, Richard
    Ryan, Andrew
    Lawrentschuk, Nathan
    Katz, Darren
    Grummet, Jeremy
    See, Andrew
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 76 - 76
  • [36] Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer
    Pos, FJ
    Horenblas, S
    Lebesque, J
    Moonen, L
    Schneider, C
    Sminia, P
    Bartelink, H
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 696 - 705
  • [37] Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy
    Nasser, Nicola J.
    Wang, Yinkun
    Borg, Jette
    Saibishkumar, Elantholi P.
    [J]. BRACHYTHERAPY, 2014, 13 (04) : 369 - 374
  • [38] Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy
    Spadinger, Ingrid
    Chu, Jackson
    Golshan, Maryam Afsari
    Keyes, Mira
    Pickles, Tom
    Hamm, Jeremy
    Morris, W. James
    [J]. BRACHYTHERAPY, 2015, 14 (03) : 350 - 358
  • [39] Low-dose-rate brachytherapy for prostate cancer: A 15-year experience in Japan
    Tanaka, Nobumichi
    Asakawa, Isao
    Hasegawa, Masatoshi
    Fujimoto, Kiyohide
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (01) : 17 - 23
  • [40] Low-dose-rate brachytherapy for prostate cancer stands the test of time - the Swiss experience
    Langley, Stephen E. M.
    [J]. BJU INTERNATIONAL, 2020, 125 (06) : 750 - 751